Dupont Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,202
Closed -$79.4K 373
2023
Q2
$79.4K Sell
2,202
-251
-10% -$8.56K ﹤0.01% 452
2023
Q1
$93.7K Sell
2,453
-8,191
-77% -$384K ﹤0.01% 507
2022
Q4
$606K Buy
10,644
+382
+4% +$19.6K 0.03% 496
2022
Q3
$406K Sell
10,262
-3,386
-25% -$150K 0.02% 693
2022
Q2
$601K Buy
13,648
+7,486
+121% +$324K 0.03% 635
2022
Q1
$246K Sell
6,162
-6,097
-50% -$217K 0.01% 993
2021
Q4
$493K Sell
12,259
-4,854
-28% -$181K 0.02% 794
2021
Q3
$696K Sell
17,113
-1,516
-8% -$63.4K 0.02% 719
2021
Q2
$846K Sell
18,629
-20,437
-52% -$905K 0.02% 704
2021
Q1
$1.63M Buy
39,066
+4,702
+14% +$215K 0.04% 416
2020
Q4
$1.47M Buy
34,364
+8,846
+35% +$318K 0.03% 422
2020
Q3
$671K Sell
25,518
-12,033
-32% -$335K 0.01% 636
2020
Q2
$1.01M Sell
37,551
-3,353
-8% -$75.6K 0.02% 512
2020
Q1
$736K Hold
40,904
0.02% 541
2019
Q4
$725K Buy
+40,904
New +$708K 0.02% 680
2018
Q1
Sell
-48,270
Closed -$978K 972
2017
Q4
$978K Hold
48,270
0.02% 516
2017
Q3
$838K Buy
48,270
+28,727
+147% +$389K 0.02% 564
2017
Q2
$251K Hold
19,543
0.01% 788
2017
Q1
$253K Sell
19,543
-25,788
-57% -$326K 0.01% 797
2016
Q4
$448K Buy
+45,331
New +$497K 0.01% 720

Other funds holding HALO

Dupont Capital Management's HALO Position: Q3 2023 in Review

Dupont Capital Management sold out of Halozyme (HALO) in Q3 2023, closing a stake of 2,202 shares — an estimated $79.4K sold.

Dupont Capital Management first reported a position in HALO in Q4 2016 and held it in 20 quarters. The position peaked at $1.63M in Q1 2021. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • Dupont Capital Management reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 2,202 Halozyme shares in Q3 2023, an estimated $79.4K.
  • Dupont Capital Management first reported a position in Halozyme in Q4 2016 and held it in 20 quarters.
  • Dupont Capital Management's Halozyme position peaked at $1.63M in Q1 2021.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.